Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sweeney

Showing results (841-850 of 853) with videos related to

Pageof 86
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Plos Genetics|June 27, 2009
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genesMaja Bucan, Brett S Abrahams, Kai Wang, et al.
Translational Psychiatry|September 19, 2019
NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosisNey Alliey-Rodriguez, Tamar A Grey, Rebecca Shafee, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Nature|May 1, 2009
Autism genome-wide copy number variation reveals ubiquitin and neuronal genesJoseph T Glessner, Kai Wang, Guiqing Cai, et al.
Nature|May 1, 2009
Common genetic variants on 5p14.1 associate with autism spectrum disordersKai Wang, Haitao Zhang, Deqiong Ma, et al.
The Lancet. Respiratory Medicine|October 21, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trialAndre C Kalil, Aneesh K Mehta, Thomas F Patterson, et al.
Pageof 86

Showing results (841-850 of 853) with videos related to

Sort By:
Pageof 86
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Plos Genetics|June 27, 2009
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genesMaja Bucan, Brett S Abrahams, Kai Wang, et al.
Translational Psychiatry|September 19, 2019
NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosisNey Alliey-Rodriguez, Tamar A Grey, Rebecca Shafee, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Nature|May 1, 2009
Autism genome-wide copy number variation reveals ubiquitin and neuronal genesJoseph T Glessner, Kai Wang, Guiqing Cai, et al.
Nature|May 1, 2009
Common genetic variants on 5p14.1 associate with autism spectrum disordersKai Wang, Haitao Zhang, Deqiong Ma, et al.
The Lancet. Respiratory Medicine|October 21, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trialAndre C Kalil, Aneesh K Mehta, Thomas F Patterson, et al.
Pageof 86